Xtant Medical Holdings, Inc.
US ˙ NYSEAM ˙ US98420P3082

SecurityXTNT / Xtant Medical Holdings, Inc.
InstitutionPrivate Advisor Group, LLC
Latest Disclosed Ownership85,000 shares
Latest Disclosed Value $ 47,430
Private Advisor Group, LLC ownership in XTNT / Xtant Medical Holdings, Inc.

On April 24, 2026 - Private Advisor Group, LLC filed a 13F-HR form disclosing ownership of 85,000 shares of Xtant Medical Holdings, Inc. (US:XTNT) valued at $47,430 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 85,000 shares of Xtant Medical Holdings, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $39,108 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F XTANT MED HLDGS COM NEW 98420P308 85,000 0 0.00 47 -28.79 0.0002
2026-02-17 2025-12-31 13F XTANT MED HLDGS COM NEW 98420P308 85,000 -38,000 -30.89 67 -16.46 0.0003
2025-11-13 2025-09-30 13F XTANT MED HLDGS COM NEW 98420P308 123,000 0 0.00 80 -12.22 0.0004
2025-08-11 2025-06-30 13F XTANT MED HLDGS COM NEW 98420P308 123,000 8,000 6.96 91 66.67 0.0005
2025-05-05 2025-03-31 13F XTANT MED HLDGS COM NEW 98420P308 115,000 0 0.00 54 8.00 0.0003
2025-02-03 2024-12-31 13F XTANT MED HLDGS COM NEW 98420P308 115,000 15,000 15.00 51 -25.37 0.0003
2024-10-22 2024-09-30 13F XTANT MED HLDGS COM NEW 98420P308 100,000 15,000 17.65 68 26.42 0.0004
2024-08-05 2024-06-30 13F XTANT MED HLDGS COM NEW 98420P308 85,000 47,500 126.67 54 23.26 0.0004
2024-04-30 2024-03-31 13F XTANT MED HLDGS COM NEW 98420P308 37,500 27,500 275.00 44 290.91 0.0003
2024-02-06 2023-12-31 13F XTANT MED HLDGS COM NEW 98420P308 10,000 10,000 11 0.0001
2022-07-13 2022-06-30 13F XTANT MED HLDGS COM NEW 98420P308 0 -10,000 -100.00 0 -100.00
2022-05-12 2022-03-31 13F/A-1 XTANT MED HLDGS COM NEW 98420P308 10,000 10,000 7 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.